Browsing CypCompounds in CypReact Training Set
*Reactant statuses (if known) are listed for each cytochrome P450 (CYP) enzyme
Displaying compounds 776 - 800 of 1631 in total
| CypComp ID | Name | Structure Image | CYP1A2 | CYP2A6 | CYP2B6 | CYP2C8 | CYP2C9 | CYP2C19 | CYP2D6 | CYP2E1 | CYP3A4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CC00856 | 3beta-[(6-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyloxy]-23,24,25,26,27-pentanorcucurbita-5-ene-22-al |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00855 | Lactapiperanol D |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00854 | Muconin |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00853 | (7Z,10Z,13Z,16Z,19Z)-Docosapentaenoyl-CoA |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00852 | (1R,2R,20R,53R,54S)-7,8,9,12,13,14,25,26,27,30,31,32,35,40,46,47-Hexadecahydroxy-3,18,21,38,49,55,58,62-octaoxatetradecacyclo[27.25.3.334,54.241,44.02,20.05,10.011,16.023,28.033,57.037,53.039,52.042,51.043,48.037,60]dohexaconta-5,7,9,11,13,15,23,25,27,29(57),30,32,34,39(52),40,42(51),43(48),44,46-nonadecaene-4,17,22,36,50,56,59,61-octone |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00851 | 5,6-Dimethylbicyclo[2.2.1]hepta-5-ene-2-ol |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00850 | 17-Epiestriol 17-O-(beta-D-glucuronide)(1-) |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00849 | Macrocarpal E |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00848 | Dammaradienol |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00847 | Ganglioside GM1 (d18:1/23:0) |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00846 | (6R)-2-Methyl-6-[(S)-4-methylene-2-cyclohexene-1beta-yl]-2-heptene-4-ol |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00845 | (2R)-2-Acetyltetrahydrofuran-2alpha-3alpha-4alpha-triol |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00844 | Butrol |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00843 | 2'-epi-Ginsenoynel |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00842 | (2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl (4ar,5R,6as,6BR,10S,12ar,12BR)-10-{[(2S,3R,4S,5S)-4-{[(2S,3R,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00841 | (2S)-2-[(2-{[6-({2-[(6-{[3,5-dihydroxy-2-(hydroxymethyl)-6-[(1,2,4,5-tetrahydroxy-6-oxohexan-3-yl)oxy]oxan-4-yl]oxy}-5-acetamido-4-hydroxy-2-(hydroxymethyl)oxan-3-yl)oxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl}oxy)-5-acetamido-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl)oxy]-5-acetamido-4-hydroxy-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00840 | 3,7(11)-Eudesmadien-2-one |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00839 | Mannosyl-diinositol-phosphorylceramide |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00838 | 3-Oxooctanoyl-CoA |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00837 | Ganglioside GT2 (d18:0/22:0) |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00836 | Ganoderic acid A |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00835 | Gibberellin A102 |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00834 | Avenacin A1 |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00833 | Leontogenin |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |
| CC00832 | Behenoyl-CoA(4-) |  | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant | Non-Reactant |